Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Partnership

15 Feb 2007 09:04

Plant Health Care PLC15 February 2007 15 February 2007 PLANT HEALTH CARE FORMS PARTNERSHIP WITH AMERICAN SOYBEAN ASSOCIATION Plant Health Care Inc, a wholly owned subsidiary of Plant Health Care plc("Plant Health Care") and The American Soybean Association ("ASA") announce the2007 "N-Hibit Partnership" field trail programme that will evaluate PlantHealth Care's N-Hibit Seed Treatment, as a tool to lower Soyabean Cyst Nematode(SCN) and improve soybean plant health, during the 2007 growing season. The ASA represents a significant majority of the US soybean growers who plantedsome 75 million acres of soybeans in the US last year. N-Hibit is a dry material that is not a restricted use product. It is easy toapply, has an excellent safety profile and leaves no residuals in the water,soil or on plants. University field research has shown that N-Hibit reduces SCN eggs significantly.Other replicated and commercial research trails have also shown that N-Hibitincreases root and plant growth and increases soybean yield by about 6.5 percent per acre. The active ingredient in N-Hibit and other Harp-N-Tek products is harpinprotein, which is produced by disease causing bacteria that attack plants.Harp-N-Tek products do not contain pathogens, but cause the plant to respond asthough being attacked. Harpin proteins do not enter the plant. They bind withthe plant's external harpin protein receptors, which are present on seed, aswell as foliage. This turns on the plant's natural self defence and growthsystems. Then the harpin proteins harmlessly disintegrate ASA Vice President, Rob Joslin said: "ASA views this field trial program as anopportunity for its members to maximize soybean yield and profitability, andreduce the threat of SCN damage. We believe soybean growers will want to conducttheir own on-farm trials to determine results with N-Hibit on a commercial scaleunder their own growing conditions and management systems to help document theperformance of this seed treatment." John Brady CEO of Plant Health Care said: "We are delighted to be working withthe ASA on the Field Trail Programme for N-Hibit, as it will show soybeangrowers across the US that this product is highly effective and can help themincrease yield per acre and hence their profits. This is the best introductionto the soybean industry and as a result of this association we fully expectsignificant penetration into this huge market by 2008/2009". For further information contact: Plant Health Care plcJohn Brady, CEO; phone: +1 603 525 3702E-Mail: jabrady@planthealthcare.com Tavistock ComunicationsJeremy Carey/Matt Ridsdale, phone: +44 20 7920 3150E-Mail: jcarey@tavistock.co.uk, mridsdale@tavistock.co.uk Notes to Editors: About Plant Health Care:Plant Health Care plc ("PHC") is a leading provider of natural products forplants and soil. Established in 1995 in Pittsburgh (Pennsylvania) in the UnitedStates, PHC currently has approximately 70 employees and has operations in theUS, Mexico, UK, Spain, and the Netherlands. The Company listed on the AIM marketof the London Stock Exchange in July 2004. Ticker symbol is PHC. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
28th Jun 202312:29 pmRNSHolding(s) in Company
27th Jun 20234:08 pmRNSHolding(s) in Company
27th Jun 20231:08 pmRNSDirector Shareholding
23rd Jun 20237:00 amRNSResult of Fundraising
22nd Jun 20234:35 pmRNSFundraising to raise up to US$3.6 million
14th Jun 20237:00 amRNSWilbur Ellis Agreement
13th Jun 20231:43 pmRNSResult of AGM
30th May 20237:00 amRNSHolding(s) in Company
24th May 20231:12 pmRNSHolding(s) in Company
19th May 20235:55 pmRNSPublication of Annual Report and Notice of AGM
18th May 20237:00 amRNSResult of Consultation
9th May 20237:00 amRNSPHC68949 granted first stage of approval in Brazil
2nd May 20237:10 amRNSResults for the year ended 31 December 2022
12th Apr 20232:33 pmRNSNotice of Results
5th Apr 20235:29 pmRNSHolding(s) in Company
8th Mar 20232:45 pmRNSExercise of Options
2nd Mar 20237:00 amRNSBiofungicide PHC279 Approved by US EPA
1st Mar 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Statement
30th Jan 202312:08 pmRNSSignificant Shareholder
18th Jan 20237:00 amRNSBoard Appointments
12th Jan 20237:00 amRNSNovozymes Distribution Agreement
9th Jan 20237:00 amRNSInvestor Presentation
22nd Dec 20227:00 amRNSNew Products Submitted for Regulatory Approval
28th Oct 20227:00 amRNSRegistration of Harpin in France
28th Oct 20227:00 amRNSNew distribution agreement with EDAF
27th Oct 20227:00 amRNSTrading Update
14th Oct 20225:11 pmRNSDirector/PDMR Shareholding
14th Oct 202210:39 amRNSDirector / PDMR Shareholding
26th Sep 20227:00 amRNSInterim Results
22nd Aug 20227:00 amRNSTrials agreement signed with Agrii UK
12th Aug 20227:00 amRNSGrant of Options
10th Aug 20225:04 pmRNSDirector/PDMR Shareholding
21st Jul 20222:41 pmRNSHolding(s) in Company
18th Jul 20227:02 amRNSInvestor Presentation
18th Jul 20227:00 amRNSPost-Close Trading Update
22nd Jun 202212:37 pmRNSResult of AGM
21st Jun 20227:00 amRNSCompletion of Nominated Adviser due diligence
20th Jun 20227:00 amRNSLong-term Harpin Production and Supply Agreement
6th Jun 20228:00 amRNSHolding(s) in Company
6th Jun 20228:00 amRNSHolding(s) in Company
1st Jun 20222:31 pmRNSDirector/PDMR Shareholding
25th May 20225:23 pmRNSHolding(s) in Company
23rd May 20227:30 amRNSAnnual Report & Accounts and Notice of AGM
23rd May 20227:00 amRNSNew distribution agreement with Nutrien
16th May 20227:00 amRNSHolding(s) in Company
12th May 20227:15 amRNSCEO appointment and Board changes
12th May 20227:00 amRNSResults for the year ended 31 December 2021
28th Apr 20227:00 amRNSChange of Adviser
21st Apr 20222:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.